|
| Press Releases |
|
 |
|
| Tuesday, December 6, 2022 |
|
|
Global pharma giants partner Singapore researchers to boost innovation in biologics and vaccines manufacturing |
| Leading pharma companies GSK, Sanofi and Takeda will partner with research communities from the Agency for Science, Technology and Research (A*STAR); National University of Singapore (NUS); Nanyang Technological University, Singapore (NTU Singapore) and its innovation and enterprise company, NTUitive; and Singapore Institute of Technology (SIT) to boost Singapore's biologics manufacturing capabilities. more info >> |
|
| Thursday, June 2, 2022 |
|
|
Boehringer Ingelheim Enters Global Licensing Agreement to Develop and Commercialize Innovative Antibodies from A*STAR for Targeted Cancer Therapies |
| Boehringer Ingelheim and the Agency for Science, Technology and Research (A*STAR) today announced a global licensing agreement under which Boehringer Ingelheim will obtain exclusive worldwide rights to research, develop and commercialize products based on a panel of innovative, tumor-specific antibodies from A*STAR. more info >> |
|
|
Boehringer Ingelheim Enters Global Licensing Agreement to Develop and Commercialize Innovative Antibodies from A*STAR for Targeted Cancer Therapies |
| more info >> |
|
| Thursday, September 30, 2021 |
|
|
A*STAR and Local SME Work with Vaccination Centres to Deploy AVID System for Filling Syringes |
| The Agency for Science, Technology and Research (A*STAR) has developed an Automated Vaccine Inoculation Dispenser (AVID) system, which replaces the manual step of filling injection syringes with vaccine liquid. AVID is customised for the vaccination centres which are set up by the Ministry of Health and operated by private healthcare providers. more info >> |
|
| Friday, July 31, 2020 |
|
|
Singapore Cancer Drug ETC-159 Advances Further in Clinical Trials |
| Made-in-Singapore cancer drug, ETC-159, has achieved a new developmental milestone in achieving "First Patient First Visit[1]" in Phase 1B. The first dose of ETC-159 has been administered to patients in this new phase of clinical testing, which for the first time, will look at efficacy in addition to assessing the safety of ETC-159 in treating different types of cancers. more info >> |
|
| Friday, July 24, 2020 |
|
|
MP Biomedicals and A*STAR Co-Develop Rapid Antibody Test Kit for SARS-CoV-2 |
| MP Biomedicals Asia Pacific Pte Ltd, a diagnostic corporation which has been operating for over 30 years focusing on various infectious disease testing development and manufacturing, today announced the successful development of a rapid antibody test kit for COVID-19, in collaboration with the Agency for Science, Technology and Research (A*STAR). more info >> |
|
| Tuesday, October 22, 2019 |
|
|
Fujitsu, SMU and A*STAR Launch Digital Platform Experimentation Project using Quantum-Inspired Computing and Deep Learning Technology |
| Fujitsu Limited, the Singapore Management University (SMU) and the Agency for Science, Technology and Research (A*STAR)'s Institute of High Performance Computing today announced the launch of the Digital Platform Experimentation Project. more info >> |
|
|
Fujitsu, SMU and A*STAR Launch Digital Platform Experimentation Project using Quantum-Inspired Computing and Deep Learning Technology |
| Fujitsu Limited, the Singapore Management University (SMU) and the Agency for Science, Technology and Research (A*STAR)'s Institute of High Performance Computing today announced the launch of the Digital Platform Experimentation Project. more info >> |
|
| Monday, October 21, 2019 |
|
|
富士通・シンガポール科学技術庁・Singapore Management University、「デジタルアニーラ」とディープラーニング技術を活用したプロジェクトを開始 |
| 富士通株式会社とシンガポール科学技術庁のハイパフォーマンスコンピューティング研究所（Institute of High Performance Computing）、およびSingapore Management Universityはこのたび、「FUJITSU Quantum-Inspired Computing Digital Annealer」とディープラーニング技術を活用したデジタルプラットフォーム実装プロジェクトを開始します。 more info >> |
|
| Friday, June 28, 2019 |
|
|
Singapore's Drug Development Efforts Given Additional Momentum with National Platforms |
| The nation's drug development efforts have been given additional momentum with the introduction of two new platforms, and a grant scheme for drug discovery and development. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Kincora Announces Shareholder Meeting Results
Dec 10, 2024 08:59 HKT/SGT
|
|
|
Friedman Institute Releases Report on "Analysis on Libyan Oil and Gas Supply - Italy's Strategic Role in Mediterranean Energy"
Dec 10, 2024 08:30: JST
|
|
|
Friedman Institute Releases Report on "Analysis on Libyan Oil and Gas Supply - Italy's Strategic Role in Mediterranean Energy"
Dec 10, 2024 07:30 HKT/SGT
|
|
|
Lexaria Reports: Liraglutide Processed with DehydraTECH to be Studied in Human GLP-1 Study #5
Dec 9, 2024 22:10 HKT/SGT
|
|
|
HAIN Premieres December 13, Showcasing the Power of Turkish Cinema
Dec 9, 2024 23:00 JST
|
|
|
Q2 Metals Drills 188.6 M Grading 1.56% Li2O, including 26 Metres of 2.03% Li2O, at the Cisco Lithium Property, James Bay, Quebec, Canada
Dec 9, 2024 21:52 HKT/SGT
|
|
|
Eastern River Pty Ltd Forecasts Strong Growth in the Global Corporate Bond Market in 2024, with Australian Bonds Also Showing Resilience
Dec 9, 2024 20:20 HKT/SGT
|
|
|
Fourteen new trains to drive first rail open access growth
Dec 9, 2024 20:10 JST
|
|
|
Hitachi to supply Japan's first SF6-free 300 kV circuit-breakers to Chubu Electric Power Grid
Dec 9, 2024 19:13 JST
|
|
|
China Medical System: First Prescriptions for Innovative Drug Lumeblue(R) Issued in China
Dec 9, 2024 14:00: JST
|
|
|
NEC begins sale of 100G QSFP28 ZR4 single-fiber bi-directional optical transceiver
Dec 9, 2024 14:06 JST
|
|
|
China Medical System: First Prescriptions for Innovative Drug Lumeblue(R) Issued in China
Dec 9, 2024 13:00 HKT/SGT
|
|
|
Hitachi, NTT Com Successfully Demonstrate World's First Real-Time Data Synchronization Over 600 km Using Storage
Virtualization Technology and IOWN APN
Dec 9, 2024 12:00 JST
|
|
|
Breaking Barriers in Data Communication: ULVAC & SAL join forces
Dec 9, 2024 9:00 JST
|
|
|
Business of IP Asia Forum and Entrepreneur Day Unlock IP and Innovation Potential
Dec 8, 2024 17:21 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
